StockStory.org on MSN
Moderna (MRNA) Stock Trades Up, Here Is Why
What Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped in the afternoon session after the company ...
The federal government is cutting $500 million in research money for development of mRNA vaccines, which were widely used against the COVID-19 virus. Health Secretary Robert F. Kennedy Jr. said in a ...
By casting doubt about the promise of mRNA tech, RFK Jr. is slowing progress toward highly effective therapies that could ...
Health and Human Services Secretary Robert F. Kennedy Jr. revealed his agency will be cutting funding to mRNA development, calling the vaccine technology "ineffective" and claiming it poses more risks ...
Health and Human Services Secretary Robert F. Kennedy Jr. said this week that he's pulling the plug on nearly $500 million in funding for the development of mRNA vaccines. Here's how they work.
In recent years, mRNA technology enabled the rapid development of vaccines to fight COVID-19, saving millions of lives. That same mRNA-powered approach to medicine—in which synthetic mRNA is ...
WASHINGTON (AP) — So-called mRNA vaccines saved millions of lives during the COVID-19 pandemic — and now scientists are using that Nobel Prize-winning technology to try to develop vaccines and ...
The Armenian immigrant and Flagship Pioneering visionary has spent decades turning scientific impossibilities into ...
In the closing of the recent trading day, Moderna (MRNA) stood at $26.25, denoting a -1.83% move from the preceding trading day.
Health and Human Services Secretary Robert F. Kennedy Jr. speaks as President Donald Trump listens at an event to promote his proposal to improve Americans’ access to their medical records in the East ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results